Chinese Scientists Collaborate On New AIDS Vaccine
This article was originally published in PharmAsia News
Hong Kong and Mainland China scientists are concentrating on three particular variants of HIV common among people in West China, Hong Kong and Taiwan to develop an AIDS vaccine. The scientists are basing their work on a collaborative effort by Chinese and U.S. researchers who designed a vaccine based on two of the HIV variants. The director of the new AIDS Institute in Hong Kong said the hope is the designed vaccine treating the two variants spread among drug users also will work on the third variant, spread through sex. (Click here for more
You may also be interested in...
The US FDA issued only one device-related close-out letter in October.
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.